Cargando…
The secretome of induced pluripotent stem cells reduces lung fibrosis in part by hepatocyte growth factor
INTRODUCTION: Idiopathic pulmonary fibrosis (IPF) is a progressive and irreversible fibrotic lung disease, resulting in respiratory insufficiency and reduced survival. Pulmonary fibrosis is a result of repeated alveolar epithelial microinjuries, followed by abnormal regeneration and repair processes...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4445988/ https://www.ncbi.nlm.nih.gov/pubmed/25384638 http://dx.doi.org/10.1186/scrt513 |
_version_ | 1782373354123034624 |
---|---|
author | Gazdhar, Amiq Grad, Iwona Tamò, Luca Gugger, Mathias Feki, Anis Geiser, Thomas |
author_facet | Gazdhar, Amiq Grad, Iwona Tamò, Luca Gugger, Mathias Feki, Anis Geiser, Thomas |
author_sort | Gazdhar, Amiq |
collection | PubMed |
description | INTRODUCTION: Idiopathic pulmonary fibrosis (IPF) is a progressive and irreversible fibrotic lung disease, resulting in respiratory insufficiency and reduced survival. Pulmonary fibrosis is a result of repeated alveolar epithelial microinjuries, followed by abnormal regeneration and repair processes in the lung. Recently, stem cells and their secretome have been investigated as a novel therapeutic approach in pulmonary fibrosis. We evaluated the potential of induced pluripotent stem cells (iPSC) conditioned media (iPSC-cm) to regenerate and repair the alveolar epithelium in vitro and improve bleomycin induced lung injury in vivo. METHODS: IPSC-cm was collected from cultured iPSC derived from human foreskin fibroblasts and its biological effects on alveolar epithelial wound repair was studied in an alveolar wound healing assay in vitro. Furthermore, iPSC-cm was intratracheally instilled 7 days after bleomycin induced injury in the rat lungs and histologically and biochemically assessed 7 days after instillation. RESULTS: iPSC-cm increased alveolar epithelial wound repair in vitro compared with medium control. Intratracheal instillation of iPSC-cm in bleomycin-injured lungs reduced the collagen content and improved lung fibrosis in the rat lung in vivo. Profibrotic TGFbeta1 and α-smooth muscle actin (α-sma) expression were markedly reduced in the iPSC-cm treated group compared with control. Antifibrotic hepatocyte growth factor (HGF) was detected in iPSC-cm in biologically relevant levels, and specific inhibition of HGF in iPSC-cm attenuated the antifibrotic effect of iPSC-cm, indicating a central role of HGF in iPSC-cm. CONCLUSION: iPSC-cm increased alveolar epithelial wound repair in vitro and attenuated bleomycin induced fibrosis in vivo, partially due to the presence of HGF and may represent a promising novel, cell free therapeutic option against lung injury and fibrosis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/scrt513) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4445988 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-44459882015-05-28 The secretome of induced pluripotent stem cells reduces lung fibrosis in part by hepatocyte growth factor Gazdhar, Amiq Grad, Iwona Tamò, Luca Gugger, Mathias Feki, Anis Geiser, Thomas Stem Cell Res Ther Research INTRODUCTION: Idiopathic pulmonary fibrosis (IPF) is a progressive and irreversible fibrotic lung disease, resulting in respiratory insufficiency and reduced survival. Pulmonary fibrosis is a result of repeated alveolar epithelial microinjuries, followed by abnormal regeneration and repair processes in the lung. Recently, stem cells and their secretome have been investigated as a novel therapeutic approach in pulmonary fibrosis. We evaluated the potential of induced pluripotent stem cells (iPSC) conditioned media (iPSC-cm) to regenerate and repair the alveolar epithelium in vitro and improve bleomycin induced lung injury in vivo. METHODS: IPSC-cm was collected from cultured iPSC derived from human foreskin fibroblasts and its biological effects on alveolar epithelial wound repair was studied in an alveolar wound healing assay in vitro. Furthermore, iPSC-cm was intratracheally instilled 7 days after bleomycin induced injury in the rat lungs and histologically and biochemically assessed 7 days after instillation. RESULTS: iPSC-cm increased alveolar epithelial wound repair in vitro compared with medium control. Intratracheal instillation of iPSC-cm in bleomycin-injured lungs reduced the collagen content and improved lung fibrosis in the rat lung in vivo. Profibrotic TGFbeta1 and α-smooth muscle actin (α-sma) expression were markedly reduced in the iPSC-cm treated group compared with control. Antifibrotic hepatocyte growth factor (HGF) was detected in iPSC-cm in biologically relevant levels, and specific inhibition of HGF in iPSC-cm attenuated the antifibrotic effect of iPSC-cm, indicating a central role of HGF in iPSC-cm. CONCLUSION: iPSC-cm increased alveolar epithelial wound repair in vitro and attenuated bleomycin induced fibrosis in vivo, partially due to the presence of HGF and may represent a promising novel, cell free therapeutic option against lung injury and fibrosis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/scrt513) contains supplementary material, which is available to authorized users. BioMed Central 2014-11-10 /pmc/articles/PMC4445988/ /pubmed/25384638 http://dx.doi.org/10.1186/scrt513 Text en © Gazdhar et al.; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Gazdhar, Amiq Grad, Iwona Tamò, Luca Gugger, Mathias Feki, Anis Geiser, Thomas The secretome of induced pluripotent stem cells reduces lung fibrosis in part by hepatocyte growth factor |
title | The secretome of induced pluripotent stem cells reduces lung fibrosis in part by hepatocyte growth factor |
title_full | The secretome of induced pluripotent stem cells reduces lung fibrosis in part by hepatocyte growth factor |
title_fullStr | The secretome of induced pluripotent stem cells reduces lung fibrosis in part by hepatocyte growth factor |
title_full_unstemmed | The secretome of induced pluripotent stem cells reduces lung fibrosis in part by hepatocyte growth factor |
title_short | The secretome of induced pluripotent stem cells reduces lung fibrosis in part by hepatocyte growth factor |
title_sort | secretome of induced pluripotent stem cells reduces lung fibrosis in part by hepatocyte growth factor |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4445988/ https://www.ncbi.nlm.nih.gov/pubmed/25384638 http://dx.doi.org/10.1186/scrt513 |
work_keys_str_mv | AT gazdharamiq thesecretomeofinducedpluripotentstemcellsreduceslungfibrosisinpartbyhepatocytegrowthfactor AT gradiwona thesecretomeofinducedpluripotentstemcellsreduceslungfibrosisinpartbyhepatocytegrowthfactor AT tamoluca thesecretomeofinducedpluripotentstemcellsreduceslungfibrosisinpartbyhepatocytegrowthfactor AT guggermathias thesecretomeofinducedpluripotentstemcellsreduceslungfibrosisinpartbyhepatocytegrowthfactor AT fekianis thesecretomeofinducedpluripotentstemcellsreduceslungfibrosisinpartbyhepatocytegrowthfactor AT geiserthomas thesecretomeofinducedpluripotentstemcellsreduceslungfibrosisinpartbyhepatocytegrowthfactor AT gazdharamiq secretomeofinducedpluripotentstemcellsreduceslungfibrosisinpartbyhepatocytegrowthfactor AT gradiwona secretomeofinducedpluripotentstemcellsreduceslungfibrosisinpartbyhepatocytegrowthfactor AT tamoluca secretomeofinducedpluripotentstemcellsreduceslungfibrosisinpartbyhepatocytegrowthfactor AT guggermathias secretomeofinducedpluripotentstemcellsreduceslungfibrosisinpartbyhepatocytegrowthfactor AT fekianis secretomeofinducedpluripotentstemcellsreduceslungfibrosisinpartbyhepatocytegrowthfactor AT geiserthomas secretomeofinducedpluripotentstemcellsreduceslungfibrosisinpartbyhepatocytegrowthfactor |